Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center

Fig. 3

Survival stratified by time-to-anti-PJP-treatment in PJP patients. A Survival stratified by time-to-treatment in PJP with rheumatic disease other than MDA5+ DM. B Survival stratified by time-to-treatment in PJP with MDA5+ DM. Unlike patients with other rheumatic diseases, MDA5+ DM patients seemed not to benefit from prompt anti-PJP treatment

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us